Clinical Trials Insight: 700058183

Trial Profile

Clinical Trials Insight: 700058183

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Aug 2010

At a glance

  • Drugs Usistapide (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 06 Aug 2010 New trial record
    • 11 Jul 2010 Part II results (n=60) presented at the 11th Congress on Obesity.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top